[SRNE] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -13.48%
YoY- -36.10%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 9,007 7,721 13,034 5,778 6,477 6,143 6,929 19.12%
PBT -82,213 -68,900 -69,110 -74,002 -70,654 -145,810 -55,746 29.59%
Tax -1,919 -276 309 -221 -383 -178 -3,122 -27.72%
NP -77,740 -65,195 -62,820 -64,415 -56,762 -108,071 -49,776 34.64%
Tax Rate - - - - - - - -
Total Cost 86,747 72,916 75,854 70,193 63,239 114,214 56,705 32.80%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -863.11 -844.39 -481.97 -1,114.83 -876.36 -1,759.25 -718.37 13.03%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.36 -0.36 -0.34 -0.49 -0.46 -0.88 -0.41 -8.31%
EPS Diluted -0.36 -0.36 -0.34 -0.46 -0.43 -0.88 -0.41 -8.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.